Community-based weight loss program for heart health in Washington D.C.
Cardiovascular Health and Needs Assessment in Washington D.C. - Development of a Community-Based Behavioral Weight Loss Intervention
This study is testing a community weight loss program to see if it can help African-American adults in Washington D.C. improve their heart health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 19 Years to 85 Years |
| Sex | All |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT01927783 on ClinicalTrials.gov |
What this trial studies
This study aims to develop a community-based behavioral weight loss intervention to improve heart health among African-American adults in Washington D.C. Researchers will collaborate with local church leaders to assess health needs and factors affecting cardiovascular health, such as diabetes, blood pressure, and cholesterol levels. Participants will undergo health screenings at their churches, including measurements of body mass index (BMI) and blood samples. The findings will inform future interventions tailored to the specific needs of this community.
Who should consider this trial
Good fit: Ideal candidates are adults aged 19 to 85 who attend one of the participating churches in Washington D.C.
Not a fit: Patients who are pregnant in their second or third trimester will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve heart health and reduce obesity-related risks in the African-American community.
How similar studies have performed: Previous studies have shown success with community-based interventions targeting heart health in similar populations, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: Individuals eligible for this protocol are aged 19 - 85 years, have attended or visited any church or faith-based organization in DC, Maryland, or Virginia, and are able to provide informed consent independently. Eligible participants should also speak and read English at the 8th grade level. EXCLUSION CRITERIA: Women in their second or third trimester of pregnancy at the time of enrollment will be excluded from the protocol.
Where this trial is running
Bethesda, Maryland
- National Institutes of Health Clinical Center — Bethesda, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Tiffany M Powell-Wiley, M.D. — National Heart, Lung, and Blood Institute (NHLBI)
- Study coordinator: Marie Marah, R.N.
- Email: marie.marah@nih.gov
- Phone: (301) 640-1701
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.